Xlr3c Inhibitors
Xlr3c inhibitors are chemical compounds designed to specifically target and inhibit the activity of the Xlr3c protein, a member of the X-linked lymphocyte-regulated (XLR) family of proteins. Xlr3c is thought to play a role in regulating chromatin structure, gene expression, and cellular differentiation processes. Like other members of the XLR family, Xlr3c is believed to be involved in maintaining chromatin organization, which is crucial for controlling the accessibility of DNA to transcriptional machinery. By modulating chromatin compaction and regulating the structural arrangement of DNA, Xlr3c influences how genes are expressed or silenced in response to various cellular signals. This protein's involvement in chromatin remodeling positions it as a key player in cellular processes such as the cell cycle, DNA repair, and responses to environmental stressors, all of which are essential for maintaining cellular function and homeostasis.
Inhibitors of Xlr3c work by binding to active or regulatory sites on the protein, blocking its ability to interact with chromatin or other molecular components necessary for its function. This inhibition can lead to disruptions in chromatin organization, potentially resulting in misregulated gene expression and alterations in cellular behavior. Since Xlr3c is involved in critical regulatory pathways, inhibiting its activity can affect processes such as transcriptional silencing, gene activation, and the stability of chromatin architecture. By modulating the activity of Xlr3c, these inhibitors may have broad implications for cellular processes that rely on finely tuned regulation of gene expression and chromatin dynamics. Studying the structure and function of Xlr3c inhibitors provides insights into how they impact chromatin states and gene regulation, shedding light on their role in influencing cellular architecture and behavior.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin has been shown to inhibit the expression of heat shock proteins, which may influence the expression of XLR3C, as some heat shock proteins are involved in regulating various cellular processes, including protein expression. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A has been studied for its potential to inhibit the expression of various cellular regulatory proteins, potentially impacting the expression of XLR3C, through its effects on specific signaling pathways involved in cellular regulation. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG (17-allylamino-17-demethoxygeldanamycin) has been investigated for its potential to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, through its effects on specific signaling pathways involved in cellular regulation. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Radicicol has been reported to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, by interfering with specific signaling pathways involved in cellular regulation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin has been found to inhibit the expression of various cellular regulatory proteins, potentially impacting the expression of XLR3C, by modulating signaling pathways involved in cellular regulation. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol has been studied for its potential to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, through its effects on specific signaling pathways involved in cellular regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been reported to modulate the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, by interfering with specific signaling pathways involved in cellular regulation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been investigated for its potential to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, through its effects on specific signaling pathways involved in cellular regulation. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin has demonstrated the ability to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, by modulating specific signaling pathways involved in cellular regulation. | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $99.00 $216.00 $510.00 | 11 | |
Kaempferol has been found to inhibit the expression of cellular regulatory proteins, potentially impacting the expression of XLR3C, by modulating specific signaling pathways involved in cellular regulation. | ||||||